Research Options:
Week of Expected Pricing Withdrawn
Company Name Ambrx Inc
Proposed Ticker AMBX
CUSIP 02337M101
Business Description A clinical stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates.
Lead Underwriter Stifel Nicolaus & Company, Incorporated,Wells Fargo Securities, LLC.
Co-Managers Canaccord Genuity Inc,Needham & Company, LLC,Roth Capital Partners, Inc.
Initial Shares 5,400,000
Revised Initial Shares N/A
Initial Price $12.00-$14.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.